This edition of SciTech Europa Quarterly examines the future of the digital agenda in Europe, focusing on developments in academia, technology and medicine.
Featuring interviews with and features by EU-based researchers, industry professionals and representatives, SciTech Europa Quarterly 30 includes special features on space research and innovations in drug development; as well as in-depth looks at innovation, research and industry developments in the EU’s academic and industrial scientific fields.
In her foreword to this issue, DG CONNECT’s Director for Digital, Society, Trust and Cybersecurity Despina Spanou discusses cybersecurity, online disinformation and the need for a harmonised cross-EU approach to digitisation. Elsewhere in the publication, SEQ covers such diverse topics as artificial intelligence; nanochemistry; rare diseases; and environmental sciences.
Innovation in digital and medical spaces
- SEQ speaks to Morgan Gillis, Director of EIT Digital UK, about the challenges facing UK digital disruption;
- Estonian Minister for Health and Labour Riina Sikkut explains why Estonia’s pioneering e-health programme represents the future of medicine; and
- SEQ investigates innovations and developments in medical imaging technology.
Special feature: the future of space policy
- Johann-Dietrich Wörner, Director General of the European Space Agency, tells SEQ about the Agency’s current activities and future plans;
- Elżbieta Bieńkowska, European Commissioner for Internal Market, Industry, Entrepreneurship and SMEs, speaks about the links between space innovation and defence developments; and
- University of Surrey Department of Physics head Professor Justin Read discusses the implications of new research into dark matter.
Special feature: drug development and life sciences
- Drug delivery systems firm Cylerus presents its innovative new delivery methods for dialysis patients;
- Professor Wolfgang Baumeister of the Max Planck Institute of Biochemistry, Munich, tells SEQ about his latest work on cryo-electron tomography and visualising supramolecular architecture; and
- Biotech expert and entrepreneur Dr Paul Peter Tak discusses the challenges facing experimental medicine.
- Professor Mike Barnes discusses the fraught position of medicinal cannabis in the UK; and
- Marguerite Arnold of MedPayRx describes the benefits and drawbacks of using blockchain in cannabinoid delivery.